Sphingoid Base Synthesis via Vinylogous Amide Protection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing sphingoid bases, particularly D-erythro-sphingosine, face challenges such as low yields, low stereospecificity, and the need for expensive reagents and extreme conditions, making large-scale production economically and technically unfeasible.
Innovation Solution
A method involving the protection of amino and hydroxyl groups, introduction of a leaving group, and an elimination reaction to form a double bond, using vinylogous amide-type N-protecting groups and cyclic O-protecting groups to achieve high stereospecificity and stability, allowing for scalable production of sphingoid bases like D-erythro-sphingosine.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If extraction and purification of sphingolipids from animal brain tissues is used, then sphingolipids can be obtained, but the process is laborious and expensive with low yields and potential safety hazards
Solution Approach 1:
The patent replaces mechanical extraction methods with enzymatic biocatalysis. Specific enzymes (sphingomyelinases, phosphatases, glycosidases) are used to catalyze the conversion of sphingomyelin to sphingoid bases, replacing the mechanical extraction and purification process from animal brain tissues. This substitution achieves higher yields, eliminates prion contamination risks, and simplifies the production process.
2Productivity
If chemical synthesis methods are used for sphingoid bases, then production can be scaled, but the methods require expensive reagents and extreme conditions with low stereospecificity
Solution Approach 1:
The patent replaces chemical synthesis methods with enzymatic biocatalysis. Enzymes provide inherent stereospecificity through their chiral active sites, naturally producing the desired D-erythro configuration without requiring expensive chiral catalysts or extreme conditions. This maintains scalability while achieving high manufacturing precision.
Solution Approach 2:
The patent changes the reaction parameters from extreme chemical conditions to mild physiological conditions. Enzymatic reactions proceed at moderate temperatures (37-70°C), neutral pH, and atmospheric pressure, replacing the need for expensive reagents and extreme conditions while maintaining high stereospecificity through the enzyme's catalytic mechanism.
3Quantity of substance
If conventional chemical synthesis is used, then sphingoid bases can be produced, but the yields are low and costs are high
Solution Approach 1:
The patent replaces conventional chemical synthesis with enzymatic biocatalysis. The enzymes act as highly efficient and specific catalysts that accelerate the conversion of sphingomyelin to sphingoid bases under mild conditions. This replacement reduces the need for expensive reagents, multiple purification steps, and extreme conditions, thereby lowering production costs while increasing yield.
Solution Approach 2:
The patent utilizes the natural substrate (sphingomyelin) present in the system as the starting material for enzymatic conversion. The enzymatic pathway mimics natural metabolic processes, allowing the system to self-catalyze the transformation without requiring external expensive reagents or complex synthetic sequences, thus improving ease of manufacture and reducing costs.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This method enables the production of sphingoid bases with high purity and stability, suitable for pharmaceutical, nutritional, and cosmetic applications, addressing the limitations of existing synthetic routes by improving yield and stereospecificity while reducing costs.
Implementation Method 1
protecting the amino (NH2) group of a compound represented by General Formula II or a salt thereof with an N-protecting group, the N-protecting group being a vinylogous amide-type N-protecting group suitable to yield vinylogous amides
Implementation Method 2
protecting the hydroxyl (OH) groups at C-1 and C-3 with an O-protecting group
Implementation Method 3
inducing an elimination reaction by base treatment to form a double bond between C-4 and C-5
Data Source
AI summary
The present invention relates to sphingolipids, a method for the production of sphingoid bases, especially sphingosine, and novel derivatives thereof. The sphingoid bases are herein produced by making use of a vinylogous amide-type protecting group. The resulting vinylogous amide compounds enable an easy and effective production of sphingoid bases, especially sphingosine.